BNP Paribas Financial Markets’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-94,755
| Closed | -$388K | – | 4320 |
|
|
2022
Q1 | $388K | Sell |
94,755
-17,457
| -16% | -$63.3K | ﹤0.01% | 2877 |
|
|
2021
Q4 | $401K | Buy |
112,212
+82,605
| +279% | +$289K | ﹤0.01% | 3110 |
|
|
2021
Q3 | $108K | Buy |
29,607
+23,136
| +358% | +$93.5K | ﹤0.01% | 3241 |
|
|
2021
Q2 | $28.2K | Sell |
6,471
-15,212
| -70% | -$62K | ﹤0.01% | 3448 |
|
|
2021
Q1 | $89.1K | Sell |
21,683
-10,520
| -33% | -$45.6K | ﹤0.01% | 3403 |
|
|
2020
Q4 | $128K | Sell |
32,203
-6,547
| -17% | -$21.2K | ﹤0.01% | 3094 |
|
|
2020
Q3 | $105K | Buy |
38,750
+31,644
| +445% | +$87.6K | ﹤0.01% | 3091 |
|
|
2020
Q2 | $19.5K | Sell |
7,106
-317,990
| -98% | -$887K | ﹤0.01% | 3411 |
|
|
2020
Q1 | $767K | Buy |
325,096
+306,145
| +1,615% | +$1.04M | ﹤0.01% | 2106 |
|
|
2019
Q4 | $89.1K | Sell |
18,951
-4,868
| -20% | -$19.9K | ﹤0.01% | 3342 |
|
|
2019
Q3 | $79.7K | Buy |
23,819
+6,715
| +39% | +$22.1K | ﹤0.01% | 3240 |
|
|
2019
Q2 | $56.3K | Sell |
17,104
-12,949
| -43% | -$37.5K | ﹤0.01% | 3347 |
|
|
2019
Q1 | $91.1K | Buy |
30,053
+29,998
| +54,542% | +$97.2K | ﹤0.01% | 3176 |
|
|
2018
Q4 | $150 | Sell |
55
-4,858
| -99% | -$16K | ﹤0.01% | 4134 |
|
|
2018
Q3 | $16.5K | Hold |
4,913
| – | – | ﹤0.01% | 3498 |
|
|
2018
Q2 | $12.7K | Sell |
4,913
-25,450
| -84% | -$63.3K | ﹤0.01% | 3681 |
|
|
2018
Q1 | $66.8K | Buy |
30,363
+617
| +2% | +$1.39K | ﹤0.01% | 3395 |
|
|
2017
Q4 | $59.2K | Buy |
29,746
+15,277
| +106% | +$33.2K | ﹤0.01% | 3572 |
|
|
2017
Q3 | $46.9K | Sell |
14,469
-621
| -4% | -$1.92K | ﹤0.01% | 3181 |
|
|
2017
Q2 | $48.6K | Buy |
15,090
+15,061
| +51,934% | +$42.7K | ﹤0.01% | 3210 |
|
|
2017
Q1 | $82 | Hold |
29
| – | – | ﹤0.01% | 4012 |
|
|
2016
Q4 | $68 | Hold |
29
| – | – | ﹤0.01% | 4115 |
|
|
2016
Q3 | $49 | Hold |
29
| – | – | ﹤0.01% | 3512 |
|
|
2016
Q2 | $30 | Buy |
+29
| New | +$28 | ﹤0.01% | 3538 |
|
|
2016
Q1 | – | Sell |
-28,694
| Closed | -$34.7K | – | 3220 |
|
|
2015
Q4 | $34.7K | Sell |
28,694
-2,622
| -8% | -$3.65K | ﹤0.01% | 3049 |
|
|
2015
Q3 | $53.2K | Buy |
31,316
+18,442
| +143% | +$36.1K | ﹤0.01% | 2816 |
|
|
2015
Q2 | $26.8K | Buy |
12,874
+10,164
| +375% | +$24.6K | ﹤0.01% | 2861 |
|
|
2015
Q1 | $7.34K | Buy |
+2,710
| New | +$6.88K | ﹤0.01% | 2933 |
|
|
2014
Q4 | – | Sell |
-6,960
| Closed | -$12.7K | – | 3450 |
|
|
2014
Q3 | $12.7K | Buy |
+6,960
| New | +$15.2K | ﹤0.01% | 3461 |
|
|
2014
Q2 | – | Sell |
-181
| Closed | -$503 | – | 3995 |
|
|
2014
Q1 | $503 | Sell |
181
-1,282
| -88% | -$5.69K | ﹤0.01% | 3045 |
|
|
2013
Q4 | $6.55K | Sell |
1,463
-29,598
| -95% | -$121K | ﹤0.01% | 2920 |
|
|
2013
Q3 | $126K | Sell |
31,061
-4,922
| -14% | -$21.5K | ﹤0.01% | 2376 |
|
|
2013
Q2 | $150K | Buy |
+35,983
| New | +$139K | ﹤0.01% | 2438 |
|
Other funds holding ATRS
BNP Paribas Financial Markets's ATRS Position: Q2 2022 in Review
BNP Paribas Financial Markets sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 94,755 shares — an estimated $388K sold.
BNP Paribas Financial Markets first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $767K in Q1 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- BNP Paribas Financial Markets reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- BNP Paribas Financial Markets sold 94,755 Antares Pharma, Inc. shares in Q2 2022, an estimated $388K.
- BNP Paribas Financial Markets first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
- BNP Paribas Financial Markets's Antares Pharma, Inc. position peaked at $767K in Q1 2020.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2022, filed 12 Aug 2022.